Old Web
English
Sign In
Acemap
>
authorDetail
>
Bin Luo
Bin Luo
Novo Nordisk
Randomized controlled trial
Insulin degludec
Type 2 diabetes
Metformin
Medicine
2
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Preserved pharmacokinetics and pharmacodynamics of insulin degludec and liraglutide when administered as insulin degludec/liraglutide in a Chinese population.
2021
Journal of Diabetes Investigation
Hongzhong Liu
Bin Luo
Xia Chen
Steen H. Ingwersen
Ting Jia
Lisbeth V. Jacobsen
Pei Hu
Show All
Source
Cite
Save
Citations (0)
DUAL II China: Superior HbA1c reductions and weight loss with insulin degludec/liraglutide (IDegLira) versus insulin degludec in a randomized trial of Chinese people with type 2 diabetes inadequately controlled on basal insulin.
2021
Diabetes, Obesity and Metabolism
Yu Pei
Bue R. Agner
Bin Luo
Xiaolin Dong
Dongmei Li
Jun Liu
Lei Liu
Ming Liu
Yibing Lu
Tomoyuki Nishida
Xiangjin Xu
Yiming Mu
Show All
Source
Cite
Save
Citations (0)
1